SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 38 filers reported holding SCPHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,025,280 | -30.1% | 144,000 | 0.0% | 0.02% | -28.6% |
Q2 2023 | $1,467,360 | -15.8% | 144,000 | -25.1% | 0.04% | -23.9% |
Q1 2023 | $1,743,254 | +26.5% | 192,200 | 0.0% | 0.05% | +27.8% |
Q4 2022 | $1,378,074 | +59.9% | 192,200 | +45.4% | 0.04% | +56.5% |
Q3 2022 | $862,000 | +35.3% | 132,200 | 0.0% | 0.02% | +53.3% |
Q2 2022 | $637,000 | -15.2% | 132,200 | 0.0% | 0.02% | 0.0% |
Q1 2022 | $751,000 | +13.1% | 132,200 | 0.0% | 0.02% | +25.0% |
Q4 2021 | $664,000 | -24.5% | 132,200 | 0.0% | 0.01% | -29.4% |
Q3 2021 | $879,000 | +40.9% | 132,200 | +29.4% | 0.02% | +54.5% |
Q2 2021 | $624,000 | -8.6% | 102,200 | -0.5% | 0.01% | -15.4% |
Q1 2021 | $683,000 | +133.9% | 102,700 | +162.0% | 0.01% | +85.7% |
Q3 2020 | $292,000 | +1.0% | 39,200 | 0.0% | 0.01% | +16.7% |
Q2 2020 | $289,000 | -39.2% | 39,200 | -38.9% | 0.01% | -45.5% |
Q1 2020 | $475,000 | +30.9% | 64,200 | 0.0% | 0.01% | +120.0% |
Q4 2019 | $363,000 | -0.3% | 64,200 | +4.4% | 0.01% | 0.0% |
Q3 2019 | $364,000 | +85.7% | 61,500 | 0.0% | 0.01% | +66.7% |
Q2 2019 | $196,000 | +1.6% | 61,500 | -4.4% | 0.00% | +50.0% |
Q1 2019 | $193,000 | +257.4% | 64,300 | +349.7% | 0.00% | +100.0% |
Q4 2018 | $54,000 | -86.8% | 14,300 | -79.4% | 0.00% | -75.0% |
Q3 2018 | $408,000 | +3.8% | 69,500 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $393,000 | -54.4% | 69,500 | 0.0% | 0.00% | -55.6% |
Q1 2018 | $862,000 | – | 69,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |